
Cortical Dynamics Ltd is an Australian neurotechnology startup based in Perth that develops innovative brain monitoring technologies and AI-based applications for the global market of over 200 million annual operations involving general anaesthetics, analgesics, and opioids. Their flagship product, the Brain Anaesthesia Response Monitor (BARM™), was developed with leading anaesthesiologists to improve detection of anaesthetic effects on brain activity, aiding optimal patient medication during surgery. BARM™ is FDA (510k), CE, TGA, and Korean MFDS approved, with a next-generation version in development for clinical trials and commercial rollout in 2026. The company’s technology offers improved patient outcomes, reduces hospital costs, and supports opioid-sparing techniques aligned with Enhanced Recovery After Surgery (ERAS) protocols. Cortical Dynamics also has a licensing agreement with Philips Healthcare to integrate BARM™ with Philips monitoring systems, positioning it as a key player in advanced brain monitoring in operating theatres and potentially ICUs and ERs.

Cortical Dynamics Ltd is an Australian neurotechnology startup based in Perth that develops innovative brain monitoring technologies and AI-based applications for the global market of over 200 million annual operations involving general anaesthetics, analgesics, and opioids. Their flagship product, the Brain Anaesthesia Response Monitor (BARM™), was developed with leading anaesthesiologists to improve detection of anaesthetic effects on brain activity, aiding optimal patient medication during surgery. BARM™ is FDA (510k), CE, TGA, and Korean MFDS approved, with a next-generation version in development for clinical trials and commercial rollout in 2026. The company’s technology offers improved patient outcomes, reduces hospital costs, and supports opioid-sparing techniques aligned with Enhanced Recovery After Surgery (ERAS) protocols. Cortical Dynamics also has a licensing agreement with Philips Healthcare to integrate BARM™ with Philips monitoring systems, positioning it as a key player in advanced brain monitoring in operating theatres and potentially ICUs and ERs.